“Evaluation of serum Cystatin C as a predictor of eGFR in type 2 diabetic patients with nephropathy”, J Shalamar Med Dent Coll, vol. 6, no. 1, pp. 03–08, Jun. 2025, doi: 10.53685/jshmdc.v6i1.294.